Fortress Biotech Subsidiary, Altamira Bio, Acquires NIH License and CRADAs Relating to the Development of N-acetyl-D-mannosamine (ManNAc) for Rare Genetic Disorders Jul 17, 2015
Fortress Biotech Reports Financial Results for the First Quarter 2015 Ended March 31, 2015 May 11, 2015
